共同药业 (300966)

Hubei Goto Biopharm Co.,Ltd.

ASZ

Tags

Special Purpose LoansPharmaceutical ManufacturingSynthetic BiologyContains Convertible BondsMicro Cap StocksMargin Trading and Securities LendingAssisted Reproduction

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 11528.11
  • Circulating A-Shares(W): 7636.82
  • Earnings Per Share(RMB): -0.2800
  • Net Assets Per Share(RMB): 6.7220
  • Operating Revenue(W RMB): 45507.13
  • Total Profit(W RMB): -5365.80
  • Net Profit Attributable to Parent(W RMB): -3243.49
  • Net Profit Growth Rate(%): -129.02
  • Weighted Return on Equity(%): -3.6100
  • Operating Cash Flow Per Share(RMB): -0.0540
  • Undistributed Profit Per Share(RMB): 2.2413
  • Capital Reserve Per Share(RMB): 3.5658

2. Main Business

The main business covers:

  • R&D, production and sales of steroid drug raw materials

3. Company Basic Information

  • Company Name: Hubei Goto Biopharm Co., Ltd.
  • Listing Date: 2021-04-09
  • Industry: Pharmaceutical Manufacturing
  • Address: 33F, Building 1, Global Financial City, Jiangshan South Road, Wolong Avenue, Fancheng District, Xiangyang City, Hubei Province
  • Website: www.gotopharm.com
  • Company Profile：In December 2005, natural person shareholders Xi Zubin and Xu Runxing signed the "Capital Contribution Agreement" to jointly invest in establishing Goto Co., Ltd. In April 2006, the shareholders of Goto Co., Ltd. held a shareholders' meeting and passed a resolution on the election of the company's executive director, supervisor, and general manager. At the time of establishment, the company's registered capital was RMB 3 million. Shareholder Xi Zubin subscribed to RMB 1.5 million, accounting for 50% of the total registered capital, and shareholder Xu Runxing subscribed to RMB 1.5 million, accounting for 50% of the total registered capital. The above subscribed capital was to be paid in two installments. In April 2006, Xiangfan Yuanda Accounting Firm Co., Ltd. issued the Xiang Yuanda Yan Zi (2006) No. 154 "Capital Verification Report", verifying that as of March 31, 2006, Goto Co., Ltd. had received the first installment of registered capital paid by shareholders amounting to RMB 750,000. Among them, Xi Zubin actually contributed RMB 750,000, all in monetary form, while shareholder Xu Runxing did not make any actual contribution. The above capital verification report has been reviewed by Dahua Certified Public Accountants and the "Special Review Report" (Dahua Yan Zi [2020] No. 5-00003) was issued on March 15, 2020. In May 2006, the Yicheng City Administration for Industry and Commerce approved the establishment of Goto Co., Ltd. The company was established by changing the organizational form of Yicheng Goto Pharmaceutical Co., Ltd.; the company is registered with the Xiangyang City Administration for Industry and Commerce in Hubei Province and obtained a business license with the Unified Social Credit Code: 91420684795913849E.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Danjiangkou Goto Innovation Investment Partnership (Limited Partnership) General Legal Person 510.65 6.69
2 Zhejiang Huahai Pharmaceutical Co., Ltd. General Legal Person 200.69 2.63
3 Shenzhen Jiajun Lihao Investment Development Co., Ltd. General Legal Person 136.67 1.79
4 Hubei Gaojin Biotechnology Venture Capital Fund Partnership (Limited Partnership) General Legal Person 129.25 1.69
5 Guotai Jiatai Stock Special Pension Product - China Merchants Bank Co., Ltd. Asset Management Plan 116.49 1.53
6 Changjiang Securities Co., Ltd. Securities Firm 44.56 0.58
7 CITIC-Prudential Jingqi Youxuan Hybrid Securities Investment Fund Class A Fund 10.67 0.14

5. Concept Sectors

  • Convertible Bonds
  • Assisted Reproduction
  • Synthetic Biology
  • Margin Trading & Securities Lending
  • Micro-Cap Stocks
  • Consecutive Losses
  • Special Loans

Remarks

  • Data update date: 2026-01-01
  • Data source: Public Market Information